FutureX, developed by a global consortium including Stanford, Princeton, and Fudan, measures how well AI agents anticipate ...

Biopharmaceutical companies need exponential improvements in both time to market and efficiency in clinical trials. There is no room for costly delays due to manual processes or slow trial enrollment.